Clinical Trial Update: Phase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque Psoriasis [Phase 4]

View source ↗

Summary

Phase IV trial evaluating the efficacy and safety of Vunakizumab in adults with moderate-to-severe plaque psoriasis; the study is currently NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Vunakizumab (Vunakizumab)

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Moderate to Severe Plaque Psoriasis | Phase 4 | Status: NOT_YET_RECRUITING